Interferon γ Eliminates Responding Cd4 T Cells during Mycobacterial Infection by Inducing Apoptosis of Activated Cd4 T Cells by Dalton, Dyana K. et al.
 
J. Exp. Med. 
 
Ó
 
 The Rockefeller University Press • 0022-1007/2000/07/117/06 $5.00
Volume 192, Number 1, July 3, 2000 117–122
http://www.jem.org/cgi/current/full/192/1/117
 
Brief Deﬁnitive Report
 
117
 
Interferon 
 
g
 
 Eliminates Responding CD4 
T Cells during Mycobacterial Infection by 
Inducing Apoptosis of Activated CD4 T Cells
 
By Dyana K. Dalton, Laura Haynes, Cong-Qiu Chu, Susan L. Swain, 
and Susan Wittmer
 
From The Trudeau Institute, Saranac Lake, New York 12983
 
Abstract
 
In 
 
Mycobacterium bovis
 
 Bacille Calmette-Guérin (BCG)-infected wild-type mice, there was a
 
large expansion of an activated (CD44
 
hi
 
) splenic CD4 T cell population followed by a rapid
contraction of this population to normal numbers. Contraction of the activated CD4 T cell
population in wild-type mice was associated with increased apoptosis of activated CD4 T cells.
 
In BCG-infected interferon (IFN)-
 
g
 
 knockout (KO) mice, the activated CD4 T cell popula-
 
tion did not undergo apoptosis. These mice accumulated large numbers of CD4
 
1
 
CD44
 
hi
 
 T
cells that were responsive to mycobacterial antigens. Addition of IFN-
 
g
 
 to cultured splenocytes
 
from BCG-infected IFN-
 
g
 
 KO mice induced apoptosis of activated CD4 T cells. IFN-
 
g
 
–medi-
ated apoptosis was abolished by depleting adherent cells or Mac-1
 
1
 
 spleen cells or by inhibiting
nitric oxide synthase. Thus, IFN-
 
g
 
 is essential to a regulatory mechanism that eliminates acti-
vated CD4 T cells and maintains CD4 T cell homeostasis during an immune response.
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Introduction
 
During immune responses, large numbers of activated T
cell effectors are generated. The majority of these cells are
eliminated by apoptosis to restore the T cell compartment
to homeostasis (1). Three major pathways for terminating
immune responses have been identified (for review see ref-
erence 2). Fas–Fas ligand (FasL) interactions mediate activa-
tion-induced cell death. CTLA-4 expression on T cells in-
hibits the proliferation of activated T cells. IL-2 promotes
activation and then apoptosis of T cells. Mice lacking Fas,
FasL, CTLA-4, IL-2, or IL-2R accumulate activated T cells
and are susceptible to autoimmune disease (2, 3). However,
it is not clear whether these molecules play crucial roles in
terminating normal immune responses, as the T cell popu-
lation in Fas- and CTLA-4–deficient mice shows normal
expansion and contraction after in vivo antigen stimulation
(4, 5). It is important to fully understand the mechanisms
by which effector cells are eliminated after an immune re-
sponse. Mechanisms for terminating immune responses
may affect the generation of protective memory T cells and
may eliminate potentially harmful activated T cells.
 
In an earlier study, IFN-
 
g
 
 was postulated to play a criti-
cal role in death of effector CD4 T cells as a possible mech-
anism for self-tolerance (6). However, this work was done
entirely in vitro with a cloned T cell line. No in vivo evi-
dence for such a role for IFN-
 
g
 
 was presented. IFN-
 
g
 
 has
an essential role in stimulating macrophages to produce ni-
tric oxide (NO) (7). Macrophages restrict the expansion of
splenocytes in vitro to various stimuli by making NO (8).
NO is an inducer of apoptosis in a variety of cell types, in-
cluding T cell clones (9–11). However, it is evident from
numerous recent reviews of T cell downregulation that
IFN-
 
g
 
 and NO are not widely considered to have a role in
T cell downregulation and homeostasis (2, 12–15). This
may be because there is no clear in vivo evidence that acti-
vated CD4 T cells fail to undergo apoptosis and therefore
accumulate in mice lacking IFN-
 
g
 
.
We observed that during Bacille Calmette-Guérin (BCG)
infection of IFN-
 
g
 
 knockout (KO) mice, the CD4 T cell
 
population expanded markedly to comprise 30–50% of
 
total lymphocytes in the spleen and liver. Our investigation
of this phenomenon led to novel evidence that IFN-
 
g
 
 KO
mice fail to induce apoptosis of activated CD4 T cells dur-
ing BCG infection, resulting in accumulation of activated
CD4 T cells. We also found that IFN-
 
g
 
 induces apoptosis
of activated CD4 T cells in vitro during BCG infection and
that activated macrophages and NO are a part of the mech-
anism. Thus, IFN-
 
g
 
 is an essential component of a mecha-
nism for terminating immune responses.
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Apoptosis of CD4 T Cells in IFN-
 
g
 
 Knockout Mice
 
Materials and Methods
 
Infection of Mice.
 
Homozygous IFN-
 
g
 
 KO breeding pairs,
backcrossed for 10 generations onto C57BL/6, were set up to
generate IFN-
 
g
 
 KO mice (16). C57BL/6 mice (8–10 wk of age)
were used as wild-type controls. 7-wk-old B6.MRL-Fas
 
lpr
 
 (
 
lpr/lpr
 
on C57BL/6) were from The Jackson Laboratory. 
 
Mycobacterium
bovis
 
 BCG was from The Trudeau Institute Mycobacterial Col-
lection (TM 1011), stored as a live, frozen suspension. Mice were
injected intravenously through the lateral tail vein with 2 
 
3 
 
10
 
6
 
CFU of BCG in a volume of 0.2 ml. All investigations involving
mice were approved by The Trudeau Institute Institutional Ani-
mal Care and Use Committee.
 
Flow Cytometric Analysis.
 
Cells from the spleens were stained
with antibodies, collected on a FACSCalibur™ instrument (Bec-
ton Dickinson) and analyzed using CELLQuest™ software. The
following conjugated antibodies were obtained from PharMingen
or Caltag Labs.: anti-CD4–allophycocyanin (RM4-5), anti-
CD44–PE (IM7), anti-CD45RB–PE (16A), anti-CD25–PE
(3C7), and anti-CD62L–PE (MEL-14). Propidium iodide (PI;
0.25 
 
m
 
g) was added to each tube just before collection of 5,000–
20,000 live cells.
 
Proliferation of CD4 T Cells to Antigen.
 
LPS-stimulated B cell
blasts, 95% B220
 
1
 
 cells, mitomycin C treated and pulsed with an-
tigen, were prepared as described (17). 80–90% pure CD4 T cells
were enriched from the spleens of BCG-infected wild-type and
IFN-
 
g
 
 KO mice by depleting CD8
 
1
 
, B220
 
1
 
, Mac-1
 
1
 
, Gr-1
 
1
 
,
and MHC class II
 
1
 
 cells from the spleens with magnetic beads
(Miltenyi Biotec). APCs and CD4 T cells, each at 2 
 
3
 
 10
 
6
 
 cells/
ml, were cultured in the presence of antigen at 10 
 
m
 
g/ml, Con A
(3 
 
m
 
g/ml), or medium only, without IL-2. [
 
3
 
H]thymidine was
added to the wells between 24 and 40 h of culture. Purified pro-
tein derivative of 
 
M. tuberculosis
 
 (PPD) was a gift of Dr. John
Griffen (Mycos, Ft. Collins, CO). Antigen 85 protein complex
(Ag 85; lot #97.Rv.2.4.2.8.Ag85) of 
 
M. tuberculosis
 
 was obtained
from Colorado State University, produced under the National
Institute of Allergy and Infectious Diseases contract N01 AI-
75320. OVA and Con A were from Sigma-Aldrich.
 
Apoptosis Assay.
 
Cells (10
 
5
 
) were surface stained with anti-
CD4–allophycocyanin and anti-CD44–PE, washed, and then
stained with FITC-labeled annexin V and PI (R & D Systems).
At least 1,000 CD4
 
1
 
CD44
 
hi
 
 events were collected for annexin/PI
analysis. CD4
 
1
 
CD44
 
hi
 
 cells in early apoptosis (annexin
 
1
 
PI
 
2
 
)
were in the lower right quadrant of Fig. 3 A. Live cells
(annexin
 
2
 
PI
 
2
 
) were in the lower left quadrant. Dead cells
(annexin
 
1
 
PI
 
1
 
) were in the upper right quadrant.
 
Induction of Apoptosis In Vitro with IFN-
 
g
 
.
 
Splenocytes were
cultured at a 5 
 
3
 
 10
 
6
 
 cells/ml in 0.32-cm
 
2
 
 wells in T cell me-
dium, which is RPMI 1640 with penicillin, streptomycin,
glutamine, 2-ME, and 7.5% FBS (Hyclone), with recombinant
murine IL-2 at 80 U/ml (R & D Systems). Purified recombinant
mouse IFN-
 
g
 
 at 10 ng/ml (R & D Systems) was added to induce
apoptosis. Induction of apoptosis was monitored over a 65-h time
course using the annexin/PI assay. N
 
G
 
-methyl-
 
l
 
-arginine (LMNA)
was obtained from Sigma-Aldrich and used at a concentration of
1 mM.
In some experiments, 99% of splenic Mac-1
 
1
 
 cells were re-
moved by magnetic bead depletion using CD11b Microbeads
(Miltenyi Biotec). CD4 T cells (80–95% pure) were enriched
with CD4 Microbeads and positive selection columns (Miltenyi
Biotec). Adherent cells were depleted by culture of whole spleen
in tissue culture flasks for 2 h at 37
 
8
 
C, and then nonadherent cells
were removed to another plate. Adherent PECs, 80–90% mac-
 
rophages, were prepared from BCG-infected wild-type mice as
described (18).
 
Results
 
Accumulation of Activated Splenic CD4 T Cells in IFN-
 
g
 
KO Mice.
 
Wild-type and IFN-
 
g
 
 KO mice were infected
intravenously with 2 
 
3 
 
10
 
6
 
 CFU of BCG. This resulted in
3 
 
3
 
 10
 
5
 
 CFU in the spleens at the time of infection. At 3
wk of BCG infection, wild-type spleens had an average of
3.9 
 
3
 
 10
 
6
 
 CFU, and IFN-
 
g
 
 KO spleens had an average of
2.4 
 
3
 
 10
 
7
 
 CFU. These organisms were not rapidly cleared
in the wild-type mice, persisting at 1–3 
 
3
 
 10
 
5
 
 CFU in the
spleen for 8 wk. In IFN-
 
g
 
 KO mice, the BCG organisms
grew in an uncontrolled manner due to an impairment of
macrophage activation in the absence of IFN-
 
g
 
 (16).
We monitored the number of activated CD4 T cells in
the spleens of mice during BCG infection using CD44
 
hi
 
 as
a marker for activation. When naive cells encounter anti-
gen and are activated to become effectors, there is a stable
upregulation of CD44 on the cell surface of effectors (19).
After week 3 of BCG infection, the CD4 T cell population
in the spleens of IFN-
 
g
 
 KO mice was highly skewed to-
ward high levels of expression of CD44 (Fig. 1 A). The
CD4
 
1
 
CD44
 
hi
 
 T cells expressed low levels of CD62L and
CD45RB, consistent with an activated phenotype (20).
Fig. 1 B shows the kinetics of accumulation of splenic
CD4
 
1
 
CD44
 
hi
 
 T cells during BCG infection. The wild-
type mice showed an 
 
z
 
10-fold expansion of the activated
CD4 T cell population at 3.5 wk of infection. This was fol-
lowed by a rapid contraction of the population 1 wk later.
In the IFN-
 
g
 
 KO mice, the activated CD4 T cell popula-
tion expanded by 27-fold at 3.5 wk of infection. This pop-
ulation did not contract but accumulated to large numbers
in the spleen for several weeks. A sharp decline in the
number of activated CD4 T cells occurred at 8 wk of BCG
infection in IFN-
 
g
 
 KO mice; this coincided with cell death
in the necrotic spleen. Thus, the apparent deletion of acti-
vated CD4 T cells in IFN-
 
g
 
 KO mice was most likely a
consequence of nonspecific cell death. Furthermore, the
CD4 T cell population became increasingly skewed toward
high levels of CD44 expression during the course of infec-
tion rather than returning to the homeostasis level of 25%
CD44
 
hi
 
, as observed in BCG-infected wild-type mice (Fig.
1 C). There was no change in the number of naive CD4 T
cells or CD8 T cells in the spleens of IFN-
 
g
 
 KO mice dur-
ing BCG infection.
 
Increased CD4 T Cell Responsiveness to Mycobacterial Anti-
gens in IFN-
 
g
 
 KO Mice.
 
A large expansion of the CD4
 
1
 
CD44
 
hi
 
 T cell population was never seen in uninfected
IFN-
 
g
 
 KO mice but occurred only in response to BCG in-
fection. We investigated whether this large population of
activated CD4 T cells in IFN-
 
g
 
 KO mice was responsive
to mycobacterial antigens. Enriched CD4 T cells from
IFN-
 
g
 
 KO mice showed greatly increased proliferation, in-
corporating four to six times more [
 
3
 
H]thymidine in re- 
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sponse to both PPD and Ag 85 compared with CD4 T cells
from wild-type mice (Fig. 2). Wild-type and IFN-
 
g
 
 KO
CD4 T cells proliferated equally well to the T cell mitogen
Con A (not shown), and both failed to proliferate to an ir-
relevant antigen, OVA. These data and the increased
CD4
 
1
 
CD44
 
hi
 
 T cell numbers suggest that there were in-
creased numbers of mycobacterial antigen–specific CD4 T
cells in the spleens of BCG-infected IFN-
 
g
 
 KO mice com-
pared with BCG-infected wild-type mice. This is consis-
tent with a failure to delete antigen-specific CD4 T cells
during the immune response to BCG in IFN-
 
g
 
 KO mice.
 
Activated CD4 T Cells Underwent Increased Apoptosis in
Wild-Type but not IFN-g KO Mice. We considered the
possibility that the failure of the activated CD4 T cell pop-
ulation to contract in IFN-g KO mice might reflect a fail-
ure of these cells to undergo apoptosis. We measured apop-
tosis of activated splenic CD4 T cells during BCG infection
with a quantitative flow cytometry assay that uses annexin
V–FITC (21). The activated CD4 T cell population in
BCG-infected wild-type mice typically had more than
twice as many cells in early apoptosis as the same popula-
tion in BCG-infected IFN-g KO mice (Fig. 3 A).
We measured the kinetics of apoptosis of activated CD4
T cells during BCG infection (Fig. 3 B). On day 17 of
BCG infection, apoptosis of the activated CD4 T cell pop-
ulation in wild-type mice increased dramatically to 45–
50%, remaining high for at least 8 wk. The activated CD4
T cell population of IFN-g KO mice did not show any in-
crease in apoptosis over baseline levels during BCG infec-
tion. These data indicate that IFN-g is required, either di-
rectly or indirectly, for upregulating apoptosis of activated
CD4 T cells during BCG infection.
Fas Was Not Required for Upregulation of Apoptosis of Acti-
vated CD4 T Cells. We investigated whether Fas was in-
volved in this IFN-g–dependent pathway of apoptosis. We
infected wild-type, IFN-g KO, and Fas-deficient lpr/lpr
mice with BCG and monitored the kinetics of apoptosis of
activated CD4 T cells. Interestingly, the lpr/lpr mice be-
haved identically to wild-type mice, exhibiting a surge of
apoptosis of activated CD4 T cells on day 17 (Fig. 3 C).
Apoptosis of activated CD4 T cells in IFN-g KO mice was
significantly lower than that observed in lpr/lpr and wild-
type mice on days 17 and 28 after BCG infection. Thus,
Figure 1. Kinetics of expansion and contraction of activated CD4 T
cells during BCG infection. (A) Typical FACS® histogram plots of CD44
expression on live CD4 T cells of uninfected mice or BCG-infected
wild-type and IFN-g KO mice at 4.5 wk of BCG infection. The CD44
marker was always set on uninfected mice as shown. The CD4 T cell
population of IFN-g KO mice is extremely skewed toward high levels of
expression of CD44. (B) Total number of CD41CD44hi T cells in the
spleens of wild-type and IFN-g KO mice during BCG infection. Cells
were stained and analyzed by flow cytometry to measure CD4 and CD44
expression. Shown is the total number of CD41CD44hi T cells, calculated
as: percentage of live cells that are CD41CD44hi 3 total number of live
splenocytes. Numbers shown are average and SD of six to eight mice per
time point, done in two to three experiments per time point. (C) Kinetics
of expression of high levels of CD44 on splenic CD4 T cells during BCG
infection. Numbers shown are percentage of live CD4 T cells with
CD44hi. This is the average and SD of six to eight mice per group, done
in replicate experiments.
Figure 2. Comparison of the proliferative response of enriched CD4 T
cells to mycobacterial antigens. Shown is the D cpm: cpm of CD4 T cells
cultured with APCs prepulsed with 10 mg/ml antigen 2 cpm of CD4 T
cells incubated with APCs and no antigens.120 Apoptosis of CD4 T Cells in IFN-g Knockout Mice
increased apoptosis of activated CD4 T cells during BCG
infection required IFN-g but did not require Fas.
IFN-g Induced Apoptosis of Activated CD4 T Cells In Vitro.
We investigated whether adding exogenous IFN-g to
spleen cells from BCG-infected IFN-g KO mice could in-
duce apoptosis of CD41CD44hi T cells (Fig. 4). Addition
of IFN-g to cultures of BCG-infected IFN-g KO mice in-
duced significantly increased apoptosis of CD41CD44hi T
cells as early as 22 h, increased at 45 h, but was most dra-
matic at 65 h (Fig. 4). We obtained similar results measur-
ing apoptosis of CD41CD44hi T cells by decreased forward
and increased side light scatter (22) and by using the
TUNEL (TdT-mediated dUTP-biotin nick-end labeling)
assay for apoptosis (data not shown).
During the 65 h of culture, wild-type activated CD4 T
cells showed greater apoptosis and death than the same cells
in IFN-g KO cultures (compare wild-type versus IFN-g
KO cultures in medium, Fig. 4). In wild-type cultures, ad-
dition of IFN-g did not significantly increase apoptosis of
CD41CD44hi T cells (Fig. 4). These wild-type CD4 T
cells may be programmed to die during the culture period
by signals they received in vivo.
Activated Macrophages Were Required for IFN-g to Induce
Apoptosis of Activated CD4 T Cells. IFN-g did not kill
highly enriched CD4 T cells but did kill CD41CD44hi T
cells in whole spleen cultures (Fig. 5 A), suggesting that the
effect of IFN-g was indirect. Mac-1 or CD11b is expressed
at high levels on differentiated macrophages (23). In Mac-
1–depleted cultures, addition of IFN-g did not kill acti-
vated CD4 T cells. Similarly, depletion of adherent cells
greatly decreased the cytotoxic effects of IFN-g (Fig. 5 A).
Adherent peritoneal exudate cells (PECs) from wild-type
BCG-infected mice are highly enriched in activated mac-
rophages and have been shown to have cytotoxic effects in
vitro on tumor cells (24). We cultured wild-type PECs
with purified IFN-g KO CD4 T cells (Fig. 5 A). As the
wild-type PECs had most likely been exposed to IFN-g in
vivo, they reduced the viability of the CD41CD44hi T cells
even without addition of IFN-g. However, wild-type
PECs killed significantly more IFN-g KO CD41CD44hi T
cells with exogenously added IFN-g (Fig. 5 A).
NO Production Was Required for IFN-g to Induce Apoptosis
of Activated CD4 T Cells. We tested the effect of LMNA,
an NO synthase enzyme inhibitor, on IFN-g–induced ap-
optosis of CD41CD44hi T cells. Addition of LMNA to
wild-type cultures resulted in significantly increased per-
centages of live CD41CD44hi CD4 T cells compared with
Figure 3. Measurement of apoptosis of CD41CD44hi T cells ex vivo
during BCG infection. (A) Typical dot plots of annexin V and PI staining
of gated CD41CD44hi T cells in spleens of wild-type and IFN-g KO
mice at 4 wk of BCG infection. (B) Kinetics of apoptosis of gated
CD41CD44hi T cells from the spleens of BCG-infected wild-type and
IFN-g KO mice. A gate was set on CD41CD44hi T cells, and the per-
centage of apoptotic CD41CD44hi T cells was determined by annexin V
and PI staining. Numbers shown are the percentages of cells that are in
the early stages of apoptosis. Each point is the average and SD of at least
six to eight mice done in two to three or more separate experiments. (C)
Apoptosis of gated CD41CD44hi T cells from the spleens of BCG-infected
wild-type, lpr/lpr (on C57BL/6), and IFN-g KO mice; all three groups
were compared in the same experiment each time. Numbers shown are
percentages of CD41CD44hi T cells in early apoptosis. Each point is the
average and SD of six mice done in two separate experiments.
Figure 4. Induction of apoptosis of CD41CD44hi T cells in vitro by
IFN-g. Spleen cells from BCG-infected wild-type and IFN-g KO mice,
week 3 or 4 after infection, were cultured in medium with IL-2, with or
without IFN-g. A gate was set on CD41CD44hi T cells, and the percent-
age of cells that were live, apoptotic, and dead at 65 h of culture was de-
termined from the annexin V/PI dot plots. Each bar is the average and
SD of six mice per group, done in two different experiments. Statistical
significance (t test) between groups is shown.121 Dalton et al. Brief Definitive Report
cultures with medium only (Fig. 5 B). Addition of LMNA
along with IFN-g to IFN-g KO cultures abolished IFN-g–
induced cell death (Fig. 5 C). Similar results were obtained
using another NO inhibitor, N6-(1-iminoethyl)-dihydro-
chloride (data not shown). These data suggest that at least
part of the killing of CD41CD44hi T cells in IFN-g KO
cultures by IFN-g is mediated by NO.
Discussion
We propose that a negative feedback loop maintains
CD4 T cell homeostasis. During BCG infection, CD4 T
cells secrete IFN-g and activate macrophages to increased
microbicidal activity. Activated macrophages generate NO
and other effector molecules, such as superoxide, that en-
able them to kill the BCG organisms. In the presence of ac-
tivated macrophages, the CD4 T cells begin to undergo in-
creased apoptosis, returning the number of activated CD4
T cells to normal levels. Therefore, activated CD4 T cells
secreting IFN-g indirectly trigger their own apoptosis by
activating macrophages. As IFN-g is uniquely required for
macrophage activation, IFN-g KO mice are expected to be
lacking other macrophage effector molecules besides NO.
Whether other macrophage effector mechanisms are in-
volved is currently under investigation.
Naive 6–10-wk-old IFN-g KO mice do not spontane-
ously accumulate activated CD4 T cells in the absence of
BCG infection or an antigenic challenge. This suggests that
IFN-g is involved in regulating CD4 T cell homeostasis
only during immune responses. In contrast, mice lacking
CTLA-4, IL-2, and the common cytokine g chain receptor
spontaneously accumulate activated CD4 T cells without
apparent infection (3, 25, 26). Thus, the IFN-g KO mouse
has a novel phenotype that provides insight into the regula-
tion of the immune response.
Several recent studies provide supporting evidence for a
role of IFN-g in apoptosis of immune cells during other
infectious diseases. During infection of mice with Toxo-
plasma gondii, neutralization of IFN-g with antibody re-
sulted in decreased apoptosis in tissue sections of Peyer’s
patch lymphocytes (27). This was associated with decreased
Fas expression. In contrast, we showed that mice lacking
Fas upregulated apoptosis of activated CD4 T cells during
BCG infection identically to wild-type mice. In another
study, IFN-g KO mice infected with Trypanosome cruzi
showed decreased apoptosis of whole splenocytes (28).
However, neither study specifically addressed the role of
IFN-g in apoptosis of CD4 T cells, nor did they demon-
strate increased accumulation of activated CD4 T cells in
the absence of IFN-g. Mice lacking inducible NO synthase
showed increased numbers of CD4 T cells after infection
with Trypanosome brucei. However, the level of apoptosis of
these CD4 T cells was not measured (29).
We considered the possibility that the IFN-g KO mice
accumulated activated CD4 T cells only because of the
large difference in bacterial burden between wild-type and
IFN-g KO mice. However, for several reasons we think it
is more likely that the principal cause for accumulation of
activated CD4 T cells was the failure to induce apoptosis of
these cells in the absence of IFN-g. First, BCG proved to
be a very persistent pathogen in both wild-type and IFN-g
KO mice. The bacterial burden in wild-type spleens did
not fall below the initiating number of z105 CFU during
the entire 8 wk of BCG infection. However, elimination
of the activated CD4 T cells in wild-type spleens occurred
well before the bacteria were cleared. Second, the peak
numbers of activated CD4 T cells were at 3 wk of infection
in IFN-g KO mice; at this time, the bacterial burden was
only sixfold greater than in wild-type mice. Third, in the
an accompanying article in this issue by Chu et al., we
show that activated CD4 T cells fail to undergo apoptosis
and accumulate in large numbers in the spleen and central
nervous system of IFN-g KO mice during experimental
Figure 5. Activated macrophages and NO were required for IFN-g to
induce apoptosis of activated CD4 T cells. (A) The cells indicated, from
BCG-infected IFN-g KO mice or IFN-g KO CD4 T cells with wild-
type PECs, all at week 3–4 of BCG infection, were cultured in the pres-
ence or absence of IFN-g. The percentage of live CD41CD44hi T cells at
65 h of culture was measured using the annexin/PI assay. Average and SD
of three to nine mice done in multiple experiments. (B) Wild-type and
(C) IFN-g KO spleen cells, used at week 3–4 of BCG infection, were
cultured in the indicated conditions. Percent live CD41CD44hi cells at 65 h
is shown. Statistical significance (t test) between groups is shown.122 Apoptosis of CD4 T Cells in IFN-g Knockout Mice
autoimmune encephalomyelitis (30). This is an immune re-
sponse to a persisting, but noninfectious, antigen. Taken
together, these data strongly argue that IFN-g is required
to eliminate activated CD4 T cells by apoptosis during
both infectious and autoimmune disease.
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